See inside every stock. Pro
S&P 5007,723▲ 0.60%Nasdaq26,478▲ 1.18%Dow Jones52,378▲ 0.03%Nasdaq 10029,651▲ 1.29%VIX17.52▼ 4.73%US Dollar102.35▲ 0.39%Gold spot4,006▲ 0.30%WTI101.69▲ 1.79%
← UBI page
XStocksXray
Market X-Ray report · 27 October 2026

Ubisoft Entertainment (UBI)

Euronext Paris · France · prices in EUR · close of 27 Oct 2026

Key indicators

Last closeEUR 4.330
52-week range3.702 – 8.110
Return, 1 month / 3 months−18.9% / −17.5%
Return, 1 year / 3 years−45.5% / −84.1%
TrendBelow its 200-day average
RSI (14)28
Volatility (1 year)78.3%
Worst drawdown (1 year)-51.0%
Average daily value traded3.08M EUR
Dividend yield–

Market X-Ray price-based

43/ 100 · High confidence · ahead of 35% of stocks on this exchange
Trend49
Momentum31
Stability (higher is calmer)23
Liquidity86
Income–

Five-year price chart navy: price · brown: 200-day average

0.8214.7228.6242.5256.422021-112023-022024-052025-082026-10

About the company

Ubisoft Entertainment is a French video game company based in the Paris region. It develops and publishes games for consoles, computers and mobile devices, including the Assassin's Creed, Far Cry and Tom Clancy's Rainbow Six series, along with family titles such as Just Dance and Rayman. Its customers are players around the world, and it also runs online services and subscription offerings tied to its games. The company works through a network of development studios in several countries.

The shares are listed on the Euronext Paris in France under the code UBI, and the price on this page is in euros (EUR). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

Ubisoft Entertainment (UBI) trades on the Euronext Paris in France. It last closed at EUR 4.330 on 27 October 2026.

Its price-based Market X-Ray is 43 out of 100 (a weak price profile), ranking 406 of 625 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price fell 45.5% and over the last three months it fell 17.5%. Returns are price returns, dividends not included.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
Ubisoft Entertainment (UBI)

The five lenses in numbers each metric is ranked against the other stocks on Euronext Paris

Lens and metricValueScoreReading
Trend49 · WeakBelow its long-term averages and far from its highs.
Above 200-day average-11.9%
From 52-week high-45.5%
Momentum31 · WeakLagging most stocks on this exchange.
3-month return-17.5%
6-month return-12.9%
12-month return, skipping the last month-32.9%
Stability (higher is calmer)23 · WeakVolatile, with deep drawdowns.
Volatility, 1 year (lower is calmer)78.3%
Worst drawdown, 1 year (smaller is calmer)-51.0%
Liquidity86 · StrongTrades actively.
Average daily value traded3.08M EUR
Zero-volume days0.0%
Income–Pays no dividend.
Dividend yield–
Years with dividends0

Strengths

  • Liquidity: Trades actively.

Weak spots

  • Trend: Below its long-term averages and far from its highs.
  • Momentum: Lagging most stocks on this exchange.
  • Stability (higher is calmer): Volatile, with deep drawdowns.

Returns

1 week−11.3%
1 month−18.9%
3 months−17.5%
6 months−12.9%
1 year−45.5%
3 years−84.1%
5 years−90.3%

Signals

50-day / 200-day average5.118 / 4.916
Golden / death cross (60 days)Golden, 58 days ago
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.252

Technical summary

DailyBearish4 bullish · 0 neutral · 12 bearish
WeeklyStrongly bearish0 bullish · 1 neutral · 11 bearish
MonthlyStrongly bearish0 bullish · 1 neutral · 7 bearish

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Paris; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 28 Oct 2026